Smith Hayes Advisers’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$634K Sell
8,775
-12,100
-58% -$793K 0.13% 181
2015
Q4
$1.41M Buy
20,875
+455
+2% +$31.8K 0.3% 96
2015
Q3
$1.32M Sell
20,420
-1,475
-7% -$109K 0.29% 101
2015
Q2
$1.79M Buy
21,895
+100
+0.5% +$7.71K 0.35% 82
2015
Q1
$1.51M Buy
21,795
+2,975
+16% +$215K 0.3% 98
2014
Q4
$1.43M Buy
18,820
+2,820
+18% +$223K 0.3% 103
2014
Q3
$1.29M Buy
16,000
+1,775
+12% +$148K 0.3% 102
2014
Q2
$1.24M Hold
14,225
0.29% 107
2014
Q1
$1.23M Buy
14,225
+11,300
+386% +$926K 0.3% 102
2013
Q4
$236K Hold
2,925
0.08% 223
2013
Q3
$228K Sell
2,925
-1,750
-37% -$135K 0.09% 212
2013
Q2
$327K Buy
+4,675
New +$326K 0.14% 172

Other funds holding EMN

Smith Hayes Advisers's EMN Position: Q1 2016 in Review

Smith Hayes Advisers reduced its Eastman Chemical (EMN) stake by 58% in Q1 2016, selling an estimated $793K and leaving 8,775 shares worth $634K. The position accounts for 0.13% of the portfolio, ranked #181.

Smith Hayes Advisers first reported a position in EMN in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.79M in Q2 2015. 572 funds tracked by Wall St. Rank hold EMN as of Q1 2016.

  • Smith Hayes Advisers held 8,775 shares of Eastman Chemical worth $634K as of Q1 2016.
  • Smith Hayes Advisers sold 12,100 Eastman Chemical shares in Q1 2016, an estimated $793K.
  • Eastman Chemical made up 0.13% of Smith Hayes Advisers's portfolio in Q1 2016, its #181 holding.
  • Smith Hayes Advisers first reported a position in Eastman Chemical in Q2 2013 and has held it in 12 quarters since.
  • Smith Hayes Advisers's Eastman Chemical position peaked at $1.79M in Q2 2015.
  • 572 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.